Free through Q3 2026. Founding subscribers lock the founding rate for the life of the subscription.
Everything is free through the end of 2026. Coverage Alpha publishes through Q3 and Q4 earnings seasons at no cost. Paid subscriptions open in January 2027, timed to the national formulary template drops. The founding rate stays open to the first 100 subscribers, or until March 31, 2027, whichever comes first — locking $39 per month for the life of the subscription.
For the reader who wants to run the numbers rather than read the conclusions. Everything in the Individual tier, plus the maintained models that sit behind every issue.
Organization-wide access, custom coverage requests, and onboarding support for teams larger than five. Priced on scope.
Because research is bought on track record, not promises. Publishing through an entire earnings season gives you an archive to judge before anyone is asked to pay, and gives the publication time to prove it can hold the 48-hour cadence under real conditions.
The founding rate holds for as long as the subscription remains active and uninterrupted. If list pricing rises later — and it likely will as the coverage universe and the workbook library expand — founding subscribers stay at $39.
That is the design intent. Both tiers sit well below the threshold at which most organizations require additional approval, and an invoice suitable for expense submission is provided automatically.
A team license is five Pro seats: $199 per seat, plus internal distribution rights and a quarterly coverage request. It is a department license rather than a headcount calculation, and it is invoiced annually or monthly against a purchase order.
Single-company coverage is not offered, deliberately. The value of the brief is comparative. One company's pricing doctrine sets the terms every competitor in that category has to negotiate against, and that read-through is the analysis worth paying for. A brief that covered your company alone would tell you what you already know.
Every issue free through the end of the year. The first 100 subscribers lock the founding rate of $39 per month against the $59 list price — for the life of the subscription.
Independent publication. Not investment advice. Unsubscribe anytime.